NCT06251479

Brief Summary

Based on study literature, the investigators can say that our study aims to give an explanation not only from a behavioral point of view but also with respect to what are the neuronal mechanisms underlying our ability to perceive and analyze our own and others' actions. This is essential to fully understand the complexity of our social behaviors. The knowledge of these mechanisms has a high value and relevant implications for many research fields both within and outside the neurosciences. The project aims to study the neurobehavioral correlates of verbal and non-verbal communication. Through the use of non-invasive behavioral and neurophysiological techniques, the study intends to highlight the neurobehavioral markers that allow to quantify the temporal evolution of communication dynamics in healthy subjects.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Aug 2023Aug 2026

Study Start

First participant enrolled

August 16, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 28, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2026

Expected
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

December 28, 2023

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Embodiment Scale

    patients have to experience rubber hand illusion first with a silicon and and second with a robotic hand. the embodiment variance is evaluted in the two condition with the embofiment scale

    1 hour

Secondary Outcomes (1)

  • Embodiment Scale

    1 hour

Study Arms (4)

A group behavioral 1

EXPERIMENTAL

The first group will perform perceptual and verbal and non-verbal motor execution tasks, while behavioral measurement techniques will be used.

Behavioral: behavioral 1

B group behavioral 2

EXPERIMENTAL

The second group will perform the same tasks as group A and will be subjected to the same measurements as group A. Differently from group A, the members of group B will perform the experimental tasks together with another participant.

Behavioral: behavioral 2

C group neuromoulation 1

EXPERIMENTAL

The third group is identical to group A except that neurophysiological measurement techniques will also be applied.

Device: neuromodulation 1

D group neuromodulation 2

EXPERIMENTAL

The fourth group is identical to group B except that neurophysiological measurement techniques will also be applied.

Device: neuromodulation 2

Interventions

behavioral 1BEHAVIORAL

verbal and non verbal tasks

A group behavioral 1
behavioral 2BEHAVIORAL

verbal and non verbal tasks with other partecipants

B group behavioral 2

registration with neurophysiological tecniques during verbal and non verbal tasks

C group neuromoulation 1

registration with neurophysiological tecniques during verbal and non verbal tasks with other partecipants

D group neuromodulation 2

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age range between 18 and 55 years
  • written informed consent
  • healthy subjects

You may not qualify if:

  • epilepsy or at risk of epileptic seizures,
  • cardiac pacemaker wearers,
  • presence of an implanted infusion pump,
  • metal plaques in the skull or metal objects in the eye and skull taking neuroleptic drugs or tricyclic antidepressants,
  • migraine or at risk of developing this disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Centro Neurolesi Bonino Pulejo

Messina, Messina, 98124, Italy

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Caterina Formica, PhD, PSY

Study Record Dates

First Submitted

December 28, 2023

First Posted

February 9, 2024

Study Start

August 16, 2023

Primary Completion

December 28, 2023

Study Completion (Estimated)

August 16, 2026

Last Updated

March 31, 2026

Record last verified: 2026-03

Locations